{
  "experiment_id": "3b0d497c9f90f6ba1b330e8a68238661",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "fad80e5ef0b6a35a2e224357c530fdf1",
  "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "timestamp": "2025-11-13T03:57:55.005778",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"Neurofibromatosis\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"DNA sequencing\" was narrowed to \"whole genome sequencing\", which is a more specific assay type listed in the schema.\n3. \"Neurofibroma\" was narrowed to \"Cutaneous Neurofibroma\", which is a more specific tumor type listed in the schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3029,
            "output_tokens": 188
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_012KnDUHAwvEKVBaD5RWKNBP",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"Neurofibromatosis\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"DNA sequencing\" was narrowed to \"whole genome sequencing\", which is a more specific assay type listed in the schema.\n3. \"Neurofibroma\" was narrowed to \"Cutaneous Neurofibroma\", which is a more specific tumor type listed in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3029,
              "output_tokens": 188
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3029,
          "output_tokens": 188,
          "total_tokens": 3217
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n\nI made the following changes:\n1. \"NF\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"exome sequencing\" was changed to \"whole exome sequencing\" to match the exact terminology in the schema.\n3. \"sarcoma\" was capitalized to \"Sarcoma\" to match the exact enum value in the schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3023,
            "output_tokens": 168
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01FqEhvrPWrE8reCFWYgnift",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n\nI made the following changes:\n1. \"NF\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"exome sequencing\" was changed to \"whole exome sequencing\" to match the exact terminology in the schema.\n3. \"sarcoma\" was capitalized to \"Sarcoma\" to match the exact enum value in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3023,
              "output_tokens": 168
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3023,
          "output_tokens": 168,
          "total_tokens": 3191
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"Neurofibromatoses\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n\n2. \"assay by high throughput sequencer\" was narrowed to \"whole genome sequencing\", which is a specific high-throughput sequencing assay listed in the schema.\n\n3. \"Nerve Sheath Neoplasm\" was narrowed to \"Neurofibroma\", which is a specific type of nerve sheath tumor listed in the schema and commonly associated with Neurofibromatosis type 1.\n\nThese changes ensure that the metadata uses precise terminology that matches the controlled vocabulary provided in the Target Schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3038,
            "output_tokens": 233
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_017ubiDXN8rD9QVtFUBouhR2",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"Neurofibromatoses\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n\n2. \"assay by high throughput sequencer\" was narrowed to \"whole genome sequencing\", which is a specific high-throughput sequencing assay listed in the schema.\n\n3. \"Nerve Sheath Neoplasm\" was narrowed to \"Neurofibroma\", which is a specific type of nerve sheath tumor listed in the schema and commonly associated with Neurofibromatosis type 1.\n\nThese changes ensure that the metadata uses precise terminology that matches the controlled vocabulary provided in the Target Schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3038,
              "output_tokens": 233
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3038,
          "output_tokens": 233,
          "total_tokens": 3271
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "Based on the provided Target Schema and the input data, I will narrow the broad synonyms to more specific terms that match the controlled terminology. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurocutaneous syndrome\" was changed to \"Neurofibromatosis type 1\". Neurofibromatosis type 1 is a specific neurocutaneous syndrome that is listed in the Target Schema's controlled terminology.\n\n2. \"assay\": \"spectroscopy\" was narrowed to \"FTIR spectroscopy\". This is a more specific type of spectroscopy that is listed in the Target Schema's controlled terminology for assays.\n\n3. \"tumorType\": \"unknown\" was capitalized to \"Unknown\" to match the exact spelling in the Target Schema's controlled terminology.\n\nThese changes ensure that the metadata uses more precise terminology while adhering to the controlled vocabulary specified in the Target Schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3023,
            "output_tokens": 252
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_015wmpuqgyx3ynLc5utXYvnm",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Based on the provided Target Schema and the input data, I will narrow the broad synonyms to more specific terms that match the controlled terminology. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurocutaneous syndrome\" was changed to \"Neurofibromatosis type 1\". Neurofibromatosis type 1 is a specific neurocutaneous syndrome that is listed in the Target Schema's controlled terminology.\n\n2. \"assay\": \"spectroscopy\" was narrowed to \"FTIR spectroscopy\". This is a more specific type of spectroscopy that is listed in the Target Schema's controlled terminology for assays.\n\n3. \"tumorType\": \"unknown\" was capitalized to \"Unknown\" to match the exact spelling in the Target Schema's controlled terminology.\n\nThese changes ensure that the metadata uses more precise terminology while adhering to the controlled vocabulary specified in the Target Schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3023,
              "output_tokens": 252
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3023,
          "output_tokens": 252,
          "total_tokens": 3275
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with narrowed synonyms according to the Target Schema:\n\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"ELISA\",\n  \"tumorType\": \"Neurofibroma\"\n}\n\nExplanation of changes:\n1. \"diagnosis\" remained \"Not Applicable\" as it already matches an exact value in the schema.\n2. \"assay\" was changed from the broad term \"immunoassay\" to the more specific \"ELISA\" (Enzyme-Linked Immunosorbent Assay), which is a common type of immunoassay listed in the schema.\n3. \"tumorType\" was capitalized to \"Neurofibroma\" to match the exact value in the schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3025,
            "output_tokens": 174
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01FjnoyrQPC1QcGmxLV3jptK",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with narrowed synonyms according to the Target Schema:\n\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"ELISA\",\n  \"tumorType\": \"Neurofibroma\"\n}\n\nExplanation of changes:\n1. \"diagnosis\" remained \"Not Applicable\" as it already matches an exact value in the schema.\n2. \"assay\" was changed from the broad term \"immunoassay\" to the more specific \"ELISA\" (Enzyme-Linked Immunosorbent Assay), which is a common type of immunoassay listed in the schema.\n3. \"tumorType\" was capitalized to \"Neurofibroma\" to match the exact value in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3025,
              "output_tokens": 174
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3025,
          "output_tokens": 174,
          "total_tokens": 3199
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FLIPR high-throughput cellular screening\",\n  \"tumorType\": \"Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"neurofibromatosis\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"plate based reporter assay\" was replaced with \"FLIPR high-throughput cellular screening\", which is the closest match in the schema for a high-throughput plate-based assay.\n3. \"benign neurofibroma\" was simplified to \"Neurofibroma\", as the schema does not specifically list \"benign neurofibroma\" but does include \"Neurofibroma\" as a tumor type.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3031,
            "output_tokens": 217
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_018T82p54ViKZxRAQTHrtvou",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FLIPR high-throughput cellular screening\",\n  \"tumorType\": \"Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"neurofibromatosis\" was narrowed to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"plate based reporter assay\" was replaced with \"FLIPR high-throughput cellular screening\", which is the closest match in the schema for a high-throughput plate-based assay.\n3. \"benign neurofibroma\" was simplified to \"Neurofibroma\", as the schema does not specifically list \"benign neurofibroma\" but does include \"Neurofibroma\" as a tumor type."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "output_tokens": 217
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 217,
          "total_tokens": 3248
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "I've reviewed the input data and the target schema. I'll narrow the broad synonyms to more specific terms that match the controlled vocabulary in the schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"NF1-Associated Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": Changed from \"RASopathy\" to \"Noonan Syndrome\". Noonan Syndrome is a specific type of RASopathy that is listed in the target schema.\n\n2. \"assay\": \"immunoassay\" is already a specific term that exists in the target schema, so it remains unchanged.\n\n3. \"tumorType\": Changed from \"NFIB\" to \"NF1-Associated Tumor\". NFIB is not a term in the target schema, but NF1-Associated Tumor is the closest match that could represent a tumor associated with neurofibromatosis.\n\nThese changes ensure that the metadata uses more precise terminology while adhering to the controlled vocabulary specified in the target schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3026,
            "output_tokens": 259
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01H3Uw489pxX5rQ9jhLN22v5",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "I've reviewed the input data and the target schema. I'll narrow the broad synonyms to more specific terms that match the controlled vocabulary in the schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"NF1-Associated Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": Changed from \"RASopathy\" to \"Noonan Syndrome\". Noonan Syndrome is a specific type of RASopathy that is listed in the target schema.\n\n2. \"assay\": \"immunoassay\" is already a specific term that exists in the target schema, so it remains unchanged.\n\n3. \"tumorType\": Changed from \"NFIB\" to \"NF1-Associated Tumor\". NFIB is not a term in the target schema, but NF1-Associated Tumor is the closest match that could represent a tumor associated with neurofibromatosis.\n\nThese changes ensure that the metadata uses more precise terminology while adhering to the controlled vocabulary specified in the target schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3026,
              "output_tokens": 259
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3026,
          "output_tokens": 259,
          "total_tokens": 3285
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanation of changes:\n1. \"diagnosis\": Changed \"NF\" to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"assay\": Replaced \"medical imaging\" with \"conventional MRI\", which is a more specific imaging technique listed in the schema.\n3. \"tumorType\": Capitalized \"Unknown\" to match the exact enum value in the schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3019,
            "output_tokens": 162
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01B3rBJsYwgDS7zdXsRtnNum",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with narrowed synonyms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanation of changes:\n1. \"diagnosis\": Changed \"NF\" to \"Neurofibromatosis type 1\", which is a more specific diagnosis listed in the schema.\n2. \"assay\": Replaced \"medical imaging\" with \"conventional MRI\", which is a more specific imaging technique listed in the schema.\n3. \"tumorType\": Capitalized \"Unknown\" to match the exact enum value in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3019,
              "output_tokens": 162
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3019,
          "output_tokens": 162,
          "total_tokens": 3181
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "I've reviewed the input data and the target schema. I'll narrow the broad synonyms to more specific terms that match the controlled vocabulary in the schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurocristopathy\" was changed to \"Schwannomatosis\". Neurocristopathy is a broad term that includes several conditions, but Schwannomatosis is the most specific diagnosis from the provided options that fits this category.\n\n2. \"assay\": \"transcriptomics\" was narrowed to \"RNA-seq\". RNA-seq is a specific type of transcriptomics assay listed in the schema.\n\n3. \"tumorType\": \"neurolemmoma\" was changed to \"Schwannoma\". Neurolemmoma is an older term for schwannoma, and Schwannoma is the exact term provided in the schema.\n\nThese changes ensure that the metadata uses the precise terminology specified in the target schema while maintaining the original intent of the input data.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3027,
            "output_tokens": 265
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01FRv6C4tDFiKk1zpTEjcG2D",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "I've reviewed the input data and the target schema. I'll narrow the broad synonyms to more specific terms that match the controlled vocabulary in the schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurocristopathy\" was changed to \"Schwannomatosis\". Neurocristopathy is a broad term that includes several conditions, but Schwannomatosis is the most specific diagnosis from the provided options that fits this category.\n\n2. \"assay\": \"transcriptomics\" was narrowed to \"RNA-seq\". RNA-seq is a specific type of transcriptomics assay listed in the schema.\n\n3. \"tumorType\": \"neurolemmoma\" was changed to \"Schwannoma\". Neurolemmoma is an older term for schwannoma, and Schwannoma is the exact term provided in the schema.\n\nThese changes ensure that the metadata uses the precise terminology specified in the target schema while maintaining the original intent of the input data."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3027,
              "output_tokens": 265
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3027,
          "output_tokens": 265,
          "total_tokens": 3292
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with narrowed terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Schwannomatosis\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanation of changes:\n1. \"phakomatosis\" was narrowed to \"Schwannomatosis\", which is a more specific diagnosis listed in the schema.\n2. \"viability assay\" was narrowed to \"cell viability assay\", which is the exact term listed in the schema's assay options.\n3. \"tumor of cranial and spinal nerves\" was narrowed to \"Schwannoma\", which is a specific type of tumor that commonly occurs on cranial and spinal nerves and is listed in the schema's tumorType options.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3031,
            "output_tokens": 190
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01JjpX8MnLqCu7wu2nevnwJD",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with narrowed terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Schwannomatosis\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanation of changes:\n1. \"phakomatosis\" was narrowed to \"Schwannomatosis\", which is a more specific diagnosis listed in the schema.\n2. \"viability assay\" was narrowed to \"cell viability assay\", which is the exact term listed in the schema's assay options.\n3. \"tumor of cranial and spinal nerves\" was narrowed to \"Schwannoma\", which is a specific type of tumor that commonly occurs on cranial and spinal nerves and is listed in the schema's tumorType options."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "output_tokens": 190
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 190,
          "total_tokens": 3221
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4333333333333333,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 51.2210533618927,
    "token_usage": {
      "input_tokens": 30272,
      "output_tokens": 2108,
      "total_tokens": 32380
    }
  }
}